$23.16 -0.06 (-0.25%)
Amplify Weight Loss Drug & Treatment ETF (THNR)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2024 | $0.22 | 2024-12-30 | 2024-12-30 |
Dividends Summary
- Amplify Weight Loss Drug & Treatment ETF has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 297 days ago, on December 31, 2024
- The highest dividend payed out to investors during this period was $0.22 per share
- The average dividend paid during this period was $0.22 per share.
Company News
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
With more than 10% of the global population now suffering from obesity, the share prices of companies providing the latest weight-loss drugs have surged. However, according to industry observers, investors considering exposure through the newly launched weight-loss exchange-traded funds (ETFs) need to evaluate their potential. The Roundhill GLP...